Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DSC1B Inhibitors

DSC1B inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of DSC1B, a protein belonging to the cadherin family and primarily involved in cell-cell adhesion within desmosomes. Desmosomes are cellular structures critical for providing mechanical strength and stability by linking adjacent cells, particularly in tissues subject to high physical stress such as the skin, heart, and epithelial layers. DSC1B, or Desmocollin-1B, plays a vital role in the formation and maintenance of these desmosomal junctions by facilitating calcium-dependent adhesion between cells. This process is essential for maintaining the integrity and cohesion of tissues. By inhibiting DSC1B, these compounds disrupt normal desmosomal function, potentially leading to changes in cell adhesion dynamics and tissue structure.

Structurally, DSC1B inhibitors are typically designed to interfere with the extracellular or intracellular domains of the DSC1B protein. These compounds may bind to the extracellular regions, preventing the interaction between DSC1B molecules on neighboring cells, or they may disrupt intracellular interactions that stabilize desmosomal components. Inhibiting DSC1B allows researchers to study the precise role of this protein in cell adhesion and how it contributes to the organization and mechanical properties of tissues. The use of DSC1B inhibitors also sheds light on the broader cadherin family of proteins and their function in maintaining the architecture of multicellular organisms. By examining the effects of DSC1B inhibition, researchers can gain a deeper understanding of the complex processes that regulate cell-cell adhesion, tissue cohesion, and response to mechanical stress at the molecular level.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could lead to the demethylation of the DSC1B gene promoter, potentially resulting in decreased transcriptional activity of the DSC1B gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A, a histone deacetylase inhibitor, may enhance acetylation of histones associated with the DSC1B gene, which could result in the downregulation of DSC1B mRNA synthesis.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid can bind to retinoic acid receptors, altering the transcription of genes including DSC1B, which may result in the reduction of DSC1B protein synthesis.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin has been shown to downregulate the transcription of certain genes through its action on various transcription factors, potentially leading to decreased levels of DSC1B mRNA.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol is capable of activating sirtuin pathways that could lead to the downregulation of DSC1B through histone modification changes, reducing DSC1B protein levels.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyurea can disrupt the DNA replication process, which might lead to reduced expression of the DSC1B gene due to cell cycle arrest.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

This compound binds to GC-rich sequences in DNA, potentially inhibiting the binding of transcription factors to the DSC1B promoter region, resulting in decreased DSC1B mRNA production.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$46.00
$140.00
$680.00
16
(1)

As an inhibitor of the fibroblast growth factor receptor, PD173074 could lead to decreased activation of downstream signaling cascades, culminating in reduced DSC1B transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, a key regulator of protein synthesis, which could result in a decrease in DSC1B protein translation through inhibition of cap-dependent mRNA processing.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 inhibits phosphoinositide 3-kinases, which may lead to the downregulation of the AKT signaling pathway and subsequent reduction in DSC1B gene transcription.